Screener
Alnylam Pharmaceuticals ALNY EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Alnylam Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Income (loss) before income taxes | 177,806 | (41,309) | 399,459 | (43,677) |
| Provision for income taxes | (13,312) | (30,919) | (28,974) | (46,802) |
| Net income (loss) | $164,494 | $(72,228) | $370,485 | $(90,479) |
| Net income (loss) per common share — basic | $1.23 | $(0.55) | $2.78 | $(0.70) |
| Net income (loss) per common share — diluted | $1.21 | $(0.55) | $2.71 | $(0.70) |
| Weighted-average common shares — basic | 133,606 | 130,628 | 133,244 | 130,155 |
| Weighted-average common shares — diluted | 138,281 | 130,628 | 138,249 | 130,155 |
| Statements of Comprehensive Income (Loss) |
Cover / Front Matter
FAQ
- What is Alnylam Pharmaceuticals's EPS (basic)?
- Alnylam Pharmaceuticals (ALNY) reported EPS (basic) of $1.23 in Q2 2026.
- How has Alnylam Pharmaceuticals's EPS (basic) changed year-over-year?
- Alnylam Pharmaceuticals's EPS (basic) increased by 341.2% year-over-year, from -$0.51 to $1.23.
- What is the long-term trend for Alnylam Pharmaceuticals's EPS (basic)?
- Over 4 years (2021 to 2025), Alnylam Pharmaceuticals's EPS (basic) has grown at a -26.5% compound annual growth rate (CAGR), from -$7.20 to $2.10.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Alnylam Pharmaceuticals's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude